Novel insights into the management of brain metastases
- 1 December 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 23 (6) , 556-562
Abstract
This review provides available clinical evidence regarding current therapies, discusses ongoing controversies, and introduces investigational approaches in the management of brain metastases. Novel approaches to estimating prognosis of patients with brain metastases highlight the importance of tailoring treatment to each particular patient. In the setting of unfavorable prognosis, either hospice care, symptom management, or short-course whole-brain radiotherapy (WBRT) is a critical component of palliation. In the setting of favorable or intermediate prognosis, treatment options can include a slightly more prolonged course of WBRT, surgery, stereotactic radiosurgery, systemic therapy, or a combination. Selection of the appropriate treatment is influenced by the number of brain metastases, overall patient performance status and residual life expectancy, as well as an understanding of the benefits and toxicities of each modality. Recent clinical studies have shed novel insight on the temporal sequence of memory changes following WBRT. Innovative approaches to mitigating these radiation-induced memory effects are currently being investigated. Evidence-based management of brain metastases represents an evolving field of active clinical research. Ongoing and future investigations focus on the preservation of cognition and quality of life, in addition to conventional outcomes such as intracranial tumor control and survival.Keywords
This publication has 50 references indexed in Scilit:
- What Is Your Patient's GPA and Why Does It Matter? Managing Brain Metastases and the Cost of HopeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG DatabaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis methodInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic casesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Epidemiology of brain tumorsNeurology, 1985
- Radation therapy for brain metastasesAnnals of Neurology, 1980